The middle east blood plasma derivative market is expected to experience growth, with various reports predicting its size and trends through the 2030s. Estimates of the market's value by 2032 and later years vary, with some reports focusing on specific products such as fibrinogen concentrate or plasma-derived therapies. The market's growth is reportedly driven by factors including rising demand for plasma-derived therapies and a growing geriatric population.